Actively Recruiting
Clinicopathological Characteristics of Colon Cancer in Young Age
Led by Seoul National University Bundang Hospital · Updated on 2026-04-28
1400
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying colorectal cancer to understand how age and sex affect the disease's clinical, pathophysiological, and molecular characteristics. The goal is to investigate factors that influence the prognosis of colorectal cancer, including survival outcomes based on sex and molecular profiles. This observational study is sponsored by Seoul National University Bundang Hospital and aims to provide insights into colorectal cancer prognosis by analyzing these factors. The study involves patients who have been treated after being diagnosed with colorectal cancer. There are no experimental treatments or interventions provided, as it is an observational study focusing on analyzing existing patient data related to sex hormone receptors and molecular profiles. The study tracks these patients over time to observe survival and disease recurrence patterns. Participants will be followed for up to 120 months from enrollment, during which researchers will assess overall survival and disease-specific survival in relation to molecular characteristics and sex hormone receptors. They will also monitor disease-free survival until any recurrence of colorectal cancer is documented. No additional treatments are administered, and participants’ usual care continues under their healthcare providers throughout the study period.
CONDITIONS
Brief Title
Clinicopathological Characteristics of Colon Cancer in Young Age
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated after being diagnosed with colorectal cancer
You will not qualify if you...
- Patients under age of 18 years, or patients who cannot choose whether to participate or not
- Patients who refuse to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 120 months
Participants who undergo routine care for colorectal cancer are observed to analyze clinical, pathophysiological, and molecular characteristics related to prognosis.
Visits as part of routine care
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707
Actively Recruiting
Research Team
N
Nayoung Kim, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here